|
This acquisition marks UCB’s second foray into the TCE space – closely following a blockbuster licensing deal with TCE specialist, Antengene.
|
 |
|
Langlara is manufactured by Sunshine Lake Pharma, part of the HEC Group and commercialised in the US via Lanexa Biologics.
|
|
|
The approval marks an expansion of access for a genetic disorder estimated to affect one to 13 people per million worldwide.
|
|
|
The proceeds from the financing will fund Latus Bio’s operations through key clinical milestones.
|
|
|
Ozempic oral pill will be produced entirely in the US and distributed through more than 70,000 pharmacies in the US.
|
|
